Multidisciplinary care of the patient with chronic obstructive pulmonary disease

Proceedings of the American Thoracic Society

Volumn 5, Issue 4, 2008, Pages 567-571

  Kuzma, Anne Marie ^a,e   Meli, Yvonne ^b   Meldrum, Catherine ^c   Jellen, Patricia ^d   Butler Lebair, Marianne ^a   Koczen Doyle, Debra ^a   Rising, Peter ^a   Stavrolakes, Kim ^d   Brogan, Frances ^d  

^a TEMPLE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e NONE   (United States)

Author keywords

Advance directives; Multidisciplinary team; Nutritional assessment; Patient education; Travel with oxygen

Indexed keywords

AMFEBUTAMONE; DRONABINOL; MEGESTROL ACETATE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; PREDNISONE; VARENICLINE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; DAILY LIFE ACTIVITY; DEVICE; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG USE; EMPHYSEMA; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; LUNG CLEARANCE; LUNG RESECTION; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; OUTPATIENT; OXYGEN THERAPY; PATIENT ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; PULMONARY REHABILITATION; REVIEW; SMOKING CESSATION; SUPPORT GROUP; TRAVEL;

ACTIVITIES OF DAILY LIVING; ADVANCE DIRECTIVES; DELIVERY OF HEALTH CARE, INTEGRATED; DISABILITY EVALUATION; HUMANS; NUTRITIONAL SUPPORT; OXYGEN INHALATION THERAPY; PATIENT CARE PLANNING; PATIENT EDUCATION AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SOCIAL SUPPORT; TRAVEL;

EID: 43449139169     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200708-125ET     Document Type: Review

References (39)

1. Barr RG, Celli BR, Martinez FJ, Ries AL, Rennard SI, Reilly JJ, Sciurba FC, Thomashow BM, Wise RA. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med 2005;118:1415.
2. Mularski RA, Asch SM, Shrank WH, Kerr EA, Setodji CM, Adams JL, Keesey J, McGlynn EA. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest 2006;130:1844-1850.
3. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585-591.
4. Watz H, Magnussen H. Comorbidities of COPD. Internist (Berl) 2006;47:895-896, 898-900 [in German].
5. van Manen JG, Bindels PJE, Dekker FW, Ijzermans CJ, van der Zee JS, Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002;57:412-416.
6. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992;33:190-201.
7. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 1998;17:232-240.
8. Gayle RC, Spitler DL, Karper WB, Jaeger RM, Rice SN. Psychological changes in exercising COPD patients. Int J Rehabil Res 1988;11:335-342.
9. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003;65:963-970.
10. Cully J, Graham D, Stanley M, Ferguson C, Sharafkhaneh A, Souchek J, Kunik M. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006;47:312-319.
11. Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991;99:837-841.
12. Chryssidis E, Frewin DB, Frith PA, Dawes ER. Compliance with aerosol therapy in chronic obstructive lung disease. N Z Med J 1981;94:375-377.
13. Haynes RB, Taylor DW, Sackett DL. Compliance in healthcare. Baltimore, MD: Johns Hopkins University Press; 1979. pp. 1-7.
14. Johnson G, Kong D, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005;128:3198-3204.
15. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
16. Ryan GW, Wagner GJ. Pill taking "routinization": a critical factor to understanding episodic medication adherence. AIDS Care 2003;15:795-806.
17. Voelkel NF, Tuder R. COPD: exacerbation. Chest 2000;117:376-379.
18. Regueiro CR, Hamel MB, Davis RB, Desbiens N, Connors AF, Phillips RS. A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival: Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Am J Med 1998;105:366-372.
19. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422.
20. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR 2002;51:1-16.
21. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-1613.
22. Ohar J. Gender differences in chronic obstructive pulmonary disease: CME/CE disclosures. Presented at: American Thoracic Society 2005 International Conference; 2005 May 20-25; San Diego, CA.
23. 1: the Lung Health Study. JAMA 1994;272:1497-1505.
24. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166:675-679.
25. Hartman K. Tools to put cessation intervention into practice. Presented at: American College of Obstetricians and Gynecologists 48th Annual Clinical Meeting; 2000 May 20-21; San Francisco, CA.
26. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing C, Watsky EJ, Gong J, Williams KE, Reeves KR. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296:47-55.
27. Douglas E, Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 2006;296:56-63.
28. Watts S, Noble S, Smith P, Disco M. First-line pharmacotherapy for tobacco use and dependence. J Am Board Fam Pract 2002;15:489-497.
29. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
30. Ferreira I, Brooks D, Lacasse Y, Goldstein R. Nutritional support for individuals with COPD. Chest 2000;117:672-678.
31. Schols AM, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-1797.
32. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002;20:539-544.
33. Vermeeren M, Wouters EF, Nelissen LH, van Lier A, Hofman Z, Schols AM. Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2001;73:295-301.
34. Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J 2003;22:81s-86s.
35. Habel M. Advance directives: an unrealized goal [Internet]. [Accessed 2008 Jan 8]. Available from: http://www2.nursingspectrum.com/ce/self- study_modules/course.html?CCID52715
36. Lynn J, Harrold J; Center to Improve Care of the Dying. Handbook for mortals: guidance for people facing serious illness. New York: Oxford University Press; 1999. pp. 119-138.
37. Lindemann H. Evaluation of VRP1 physiotherapy. Pneumologie 1992;46:626-630.
38. Ambrosino N, Gallegari G, Galloni C, Brega S, Pinna G. Clinical evaluation of oscillating positive expiratory pressure for enhancing expectoration in diseases other than cystic fibrosis. Monaldi Arch Chest Dis 1995;50:269-275.
39. Federal Aviation Administration. Use of certain portable oxygen concentrator devices onboard aircraft. Final rule. Fed Regist 2005;70:40155-40164.